TRISALUS LIFE SCIENCES, INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.16 USD | -3.76% |
|
-5.29% | -15.27% |
| 05-30 | Canaccord Genuity Initiates TriSalus Life Sciences at Buy Rating With $12 Price Target | MT |
| 05-30 | Canaccord Genuity Starts Coverage on TriSalus Life Sciences With Buy Rating, $12 Price Target | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 194M | - | - | - | |||
| 106B | ||||||
| 24.28B | - | |||||
| 21.96B | - | |||||
| 18.16B | ||||||
| 16.37B |
